Clinical trial
Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized…
NCT00278863 · Asan Medical Center, Other · Completed
Key facts
| NCT number | NCT00278863 |
|---|---|
| Title | Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial |
| Official title | Randomized Multicenter Phase II Trial of Capecitabine Versus S-1 as First-line Treatment in Elderly Patients With Advanced or Recurrent Unresectable Gastric Cancer |
| Lead sponsor | Asan Medical Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | S-1, Capecitabine |
| Enrollment | 96 |
| Start date | Nov 1, 2004 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Jan 19, 2006 |
| Last update posted | Feb 25, 2014 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: